Cyclopharm Limited (AU:CYC) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Cyclopharm Limited has secured its first purchase orders from two US Veterans Health Administration hospitals for its Technegas System, marking a significant step in its expansion within the United States. These orders, set for a five-year term, will enable the installation of Technegas, a cutting-edge diagnostic tool for lung diseases, in early 2025, potentially enhancing care for veterans. This development could serve as a model for further agreements with other VA hospitals, promising immediate revenue generation for Cyclopharm.
For further insights into AU:CYC stock, check out TipRanks’ Stock Analysis page.